The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
Bifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome,...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/4/836 |
_version_ | 1827695169355382784 |
---|---|
author | Luisa Marras Michele Caputo Sonia Bisicchia Matteo Soato Giacomo Bertolino Susanna Vaccaro Rosanna Inturri |
author_facet | Luisa Marras Michele Caputo Sonia Bisicchia Matteo Soato Giacomo Bertolino Susanna Vaccaro Rosanna Inturri |
author_sort | Luisa Marras |
collection | DOAJ |
description | Bifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. Non-replicative strains of <i>Bifidobacterium longum</i> (NCC3001 and NCC2705) promote the differentiation of normal human epidermal keratinocytes (NHEKs), inducing a high expression of differentiation markers (keratin —KRT1—, and transglutaminase —TGM1—) and pro-regeneration markers (cathepsins), including β-defensin-1, which plays an important role in modulating the cutaneous immune response. Strains belonging to the genera <i>Bifidobacterium</i> and <i>Lactobacillus</i> can increase tight-junction proteins in NHEKs and enhance barrier function. Bifidobacteria and lactobacilli may be used as prophylactic or therapeutic agents towards enteric pathogens, antibiotic-associated diarrhea, lactose intolerance, ulcerative colitis, irritable bowel syndrome, colorectal cancer, cholesterol reduction, and control of obesity and metabolic disorders. <i>Bifidobacterium bifidum</i> showed an in vitro capability of lowering cholesterol levels thanks to its absorption into the bacterial membrane. Several strains of the species <i>Lactobacillus acidophilus</i>, <i>L. delbrueckii</i> subsp. <i>bulgaricus</i>, <i>L. casei</i>, and <i>L. gasseri</i> led to a reduced amount of serum cholesterol due to their ability to assimilate cholesterol (in vitro). <i>Lactococcus lactis</i> KF147 and <i>Lactobacillus plantarum</i> Lp81 have also been shown to reduce cholesterol levels by 12%. Clarifying the specific health mechanisms of <i>Bifidobacterium</i> and <i>Lactobacillus</i> strains in preventing high-cost pathologies could be useful for delineating effective guidelines for the treatment of infants and adults. |
first_indexed | 2024-03-10T12:20:45Z |
format | Article |
id | doaj.art-eaa9c2f4fb77433db59179c9277cfb3e |
institution | Directory Open Access Journal |
issn | 2076-2607 |
language | English |
last_indexed | 2024-03-10T12:20:45Z |
publishDate | 2021-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Microorganisms |
spelling | doaj.art-eaa9c2f4fb77433db59179c9277cfb3e2023-11-21T15:34:34ZengMDPI AGMicroorganisms2076-26072021-04-019483610.3390/microorganisms9040836The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and HypercholesterolemiaLuisa Marras0Michele Caputo1Sonia Bisicchia2Matteo Soato3Giacomo Bertolino4Susanna Vaccaro5Rosanna Inturri6Department of Medical Science and Public Health, University of Cagliari, 09042 Cagliari, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Abano Terme, 35031 Abano Terme, ItalyPharmaceutical Department, Azienda Ospedaliero Universitaria di Cagliari, 09042 Cagliari, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyBifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. Non-replicative strains of <i>Bifidobacterium longum</i> (NCC3001 and NCC2705) promote the differentiation of normal human epidermal keratinocytes (NHEKs), inducing a high expression of differentiation markers (keratin —KRT1—, and transglutaminase —TGM1—) and pro-regeneration markers (cathepsins), including β-defensin-1, which plays an important role in modulating the cutaneous immune response. Strains belonging to the genera <i>Bifidobacterium</i> and <i>Lactobacillus</i> can increase tight-junction proteins in NHEKs and enhance barrier function. Bifidobacteria and lactobacilli may be used as prophylactic or therapeutic agents towards enteric pathogens, antibiotic-associated diarrhea, lactose intolerance, ulcerative colitis, irritable bowel syndrome, colorectal cancer, cholesterol reduction, and control of obesity and metabolic disorders. <i>Bifidobacterium bifidum</i> showed an in vitro capability of lowering cholesterol levels thanks to its absorption into the bacterial membrane. Several strains of the species <i>Lactobacillus acidophilus</i>, <i>L. delbrueckii</i> subsp. <i>bulgaricus</i>, <i>L. casei</i>, and <i>L. gasseri</i> led to a reduced amount of serum cholesterol due to their ability to assimilate cholesterol (in vitro). <i>Lactococcus lactis</i> KF147 and <i>Lactobacillus plantarum</i> Lp81 have also been shown to reduce cholesterol levels by 12%. Clarifying the specific health mechanisms of <i>Bifidobacterium</i> and <i>Lactobacillus</i> strains in preventing high-cost pathologies could be useful for delineating effective guidelines for the treatment of infants and adults.https://www.mdpi.com/2076-2607/9/4/836<i>Bidifobacterium longum</i><i>Bidifobacterium bifidum</i>dermatitis syndromeeczemacholesterolSCFAs |
spellingShingle | Luisa Marras Michele Caputo Sonia Bisicchia Matteo Soato Giacomo Bertolino Susanna Vaccaro Rosanna Inturri The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia Microorganisms <i>Bidifobacterium longum</i> <i>Bidifobacterium bifidum</i> dermatitis syndrome eczema cholesterol SCFAs |
title | The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia |
title_full | The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia |
title_fullStr | The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia |
title_full_unstemmed | The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia |
title_short | The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia |
title_sort | role of bifidobacteria in predictive and preventive medicine a focus on eczema and hypercholesterolemia |
topic | <i>Bidifobacterium longum</i> <i>Bidifobacterium bifidum</i> dermatitis syndrome eczema cholesterol SCFAs |
url | https://www.mdpi.com/2076-2607/9/4/836 |
work_keys_str_mv | AT luisamarras theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT michelecaputo theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT soniabisicchia theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT matteosoato theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT giacomobertolino theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT susannavaccaro theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT rosannainturri theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT luisamarras roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT michelecaputo roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT soniabisicchia roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT matteosoato roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT giacomobertolino roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT susannavaccaro roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia AT rosannainturri roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia |